Literature DB >> 597802

Afterdischarge thresholds and kindling rates in dorsal and ventral hippocampus and dentate gyrus.

R Racine, P A Rose, W M Burnham.   

Abstract

Electrodes were implanted to dorsal hippocampus (CA1), ventral CA1, DOrsal dentate gyrus or ventral dentate gyrus. Epileptiform afterdischarge (AD) thresholds were lower in dorsal areas than in ventral areas. Dorsal areas, however, required a greater number of stimulations to develop ("kindle") a fully generalized convulsion than did ventral areas. Thresholds and kindling rates in the dentate gyrus were intermediate between dorsal and ventral CA1, except for the ventral dentate which had higher AD thresholds than ventral CA1. Secondary sites within the hippocampus subsequently kindled within a few stimulations following completion of kindling in the primary site, regardless of which hippocampal area served as the primary site.

Entities:  

Mesh:

Year:  1977        PMID: 597802     DOI: 10.1017/s0317167100025117

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  31 in total

1.  Evidence for connexin36 localization at hippocampal mossy fiber terminals suggesting mixed chemical/electrical transmission by granule cells.

Authors:  James I Nagy
Journal:  Brain Res       Date:  2012-07-06       Impact factor: 3.252

2.  Pathophysiological mechanisms underlying increased anxiety after soman exposure: reduced GABAergic inhibition in the basolateral amygdala.

Authors:  Eric M Prager; Volodymyr I Pidoplichko; Vassiliki Aroniadou-Anderjaska; James P Apland; Maria F M Braga
Journal:  Neurotoxicology       Date:  2014-08-20       Impact factor: 4.294

3.  The GABAA receptor-mediated recurrent inhibition in ventral compared with dorsal CA1 hippocampal region is weaker, decays faster and lasts less.

Authors:  Theodoros Petrides; Panagiotis Georgopoulos; George Kostopoulos; Costas Papatheodoropoulos
Journal:  Exp Brain Res       Date:  2007-03       Impact factor: 1.972

4.  Circuit-based interventions in the dentate gyrus rescue epilepsy-associated cognitive dysfunction.

Authors:  Julia B Kahn; Russell G Port; Cuiyong Yue; Hajime Takano; Douglas A Coulter
Journal:  Brain       Date:  2019-09-01       Impact factor: 13.501

5.  Towards a circuit-level understanding of hippocampal CA1 dysfunction in Alzheimer's disease across anatomical axes.

Authors:  Arjun V Masurkar
Journal:  J Alzheimers Dis Parkinsonism       Date:  2018-01-09

6.  Combined sub-threshold dosages of phenobarbital and low-frequency stimulation effectively reduce seizures in amygdala-kindled rats.

Authors:  Azam Asgari; Saeed Semnanian; Nafiseh Atapour; Amir Shojaei; Homeira Moradi; Javad Mirnajafi-Zadeh
Journal:  Neurol Sci       Date:  2014-03-08       Impact factor: 3.307

7.  Altered Expression of CXCL13 and CXCR5 in Intractable Temporal Lobe Epilepsy Patients and Pilocarpine-Induced Epileptic Rats.

Authors:  Ruohan Li; Limin Ma; Hao Huang; Shu Ou; Jinxian Yuan; Tao Xu; Xinyuan Yu; Xi Liu; Juan Yang; Yangmei Chen; Xi Peng
Journal:  Neurochem Res       Date:  2016-11-21       Impact factor: 3.996

8.  Effects of morphine and neuroleptics on wet-dog shaking behavior elicited by hippocampal stimulation in rats.

Authors:  H Araki; H Aihara
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

Review 9.  Study of the anti-seizure effects of low-frequency stimulation following kindling (a review of the cellular mechanism related to the anti-seizure effects of low-frequency electrical stimulation).

Authors:  Zohreh Ghotbeddin; Mahyar Janahmadi; Ali Yadollahpour
Journal:  Neurol Sci       Date:  2016-08-26       Impact factor: 3.307

10.  Species differences in the expression of Ahi1, a protein implicated in the neurodevelopmental disorder Joubert syndrome, with preferential accumulation to stigmoid bodies.

Authors:  Jennifer E Doering; Kelly Kane; Yi-Chun Hsiao; Cong Yao; Bingxing Shi; Amber D Slowik; Bakul Dhagat; Delisha D Scott; Jeffrey G Ault; Patrick S Page-McCaw; Russell J Ferland
Journal:  J Comp Neurol       Date:  2008-11-10       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.